“…A functional transition occurs in the liver after birth, and most of the drug-metabolizing enzymes mature during this period. Changes in expression of some phase-I enzymes during liver maturation in humans have been reported, including cytochrome P450 (P450) (Stevens et al, 2003(Stevens et al, , 2008Koukouritaki et al, 2004;Croom et al, 2009), carboxylesterase (CES) (Yang et al, 2009;Zhu et al, 2009), paraoxonase (PON) (Cole et al, 2003;Huen et al, 2009), alcohol dehydrogenase (ADH) (Smith et al, 1971), and flavin monooxygenase (FMO) (Cherrington et al, 1998;Koukouritaki et al, 2002;Hines, 2006). The dynamic changes in the ontogenic expression of these genes are thought to be responsible for the substantial pharmacokinetic differences between newborns and adults, and this contributes to differences in therapeutic efficacy and adverse drug reactions in pediatric patients (Kearns et al, 2003;Blake et al, 2005;Hines, 2007Hines, , 2008Hines, , 2013).…”